I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Shemesh, Colby S.
214
results:
Search for persons
X
Format
Online (214)
Mediatypes
E-Books (1)
Articles (Online) (175)
Bookchapter (Online) (2)
OpenAccess-fulltext (36)
Languages
german (1)
english (192)
Sorted by: Relevance
Sorted by: Year
?
1
Pharmacokinetics (PK) of Tiragolumab in First‐in‐Human Stud..:
Garralda, Elena
;
Oh, Do Youn
;
Italiano, Antoine
...
The Journal of Clinical Pharmacology. 64 (2024) 5 - p. 544-554 , 2024
Link:
https://doi.org/10.1002/..
?
2
Phase I pharmacokinetic, safety, and preliminary efficacy s..:
Shemesh, Colby S.
;
Wang, Yongsheng
;
An, Andrew
...
Cancer Chemotherapy and Pharmacology. , 2024
Link:
https://doi.org/10.1007/..
?
3
PARP inhibition with rucaparib alone followed by combinatio..:
Kristeleit, Rebecca
;
Leary, Alexandra
;
Oaknin, Ana
...
British Journal of Cancer. , 2024
Link:
https://doi.org/10.1038/..
?
4
Applying Natural Language Processing to ClinicalTrials.gov:..:
Vora, Bianca
;
Kuruvilla, Denison
;
Kim, Chloe
...
Clinical and Translational Science. 16 (2023) 12 - p. 2417-2420 , 2023
Link:
https://doi.org/10.1111/..
?
5
Early Decision Making in a Randomized Phase II Trial of Ate..:
Shemesh, Colby S.
;
Chan, Phyllis
;
Marchand, Mathilde
...
Clinical Pharmacology & Therapeutics. 114 (2023) 3 - p. 644-651 , 2023
Link:
https://doi.org/10.1002/..
?
6
Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced P..:
Ko, Andrew H
;
Kim, Kyu-Pyo
;
Siveke, Jens T
...
The Oncologist. 28 (2023) 6 - p. 553-e472 , 2023
Link:
https://doi.org/10.1093/..
?
7
Development of a pediatric physiologically-based pharmacoki..:
Huang, Weize
;
Stader, Felix
;
Chan, Phyllis
...
Frontiers in Pharmacology. 13 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
8
Personalized Cancer Vaccines: Clinical Landscape, Challenge..:
Shemesh, Colby S.
;
Hsu, Joy C.
;
Hosseini, Iraj
...
Molecular Therapy. 29 (2021) 2 - p. 555-570 , 2021
Link:
https://doi.org/10.1016/..
?
9
Atezolizumab and Bevacizumab in Patients with Unresectable ..:
Shemesh, Colby S.
;
Chan, Phyllis
;
Shao, Hui
...
Liver Cancer. 10 (2021) 5 - p. 485-499 , 2021
Link:
https://doi.org/10.1159/..
?
10
Pharmacology-based ranking of anti-cancer drugs to guide cl..:
Lemaire, Vincent
;
Shemesh, Colby S.
;
Rotte, Anand
Journal of Experimental & Clinical Cancer Research. 40 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1186/..
?
11
Application of a Two-Analyte Integrated Population Pharmaco..:
Lu, Dan
;
Lu, Tong
;
Shi, Rong
...
Pharmaceutical Research. 37 (2020) 12 - p. , 2020
Link:
https://doi.org/10.1007/..
?
12
Pharmacokinetics of polatuzumab vedotin in combination with..:
Shemesh, Colby S.
;
Agarwal, Priya
;
Lu, Tong
...
Cancer Chemotherapy and Pharmacology. 85 (2020) 5 - p. 831-842 , 2020
Link:
https://doi.org/10.1007/..
?
13
Pan‐cancer population pharmacokinetics and exposure‐safety ..:
Shemesh, Colby S.
;
Chan, Phyllis
;
Legrand, Fatema A.
...
Pharmacology Research & Perspectives. 8 (2020) 6 - p. , 2020
Link:
https://doi.org/10.1002/..
?
14
Integrated Two‐Analyte Population Pharmacokinetic Model of ..:
Lu, Dan
;
Lu, Tong
;
Gibiansky, Leonid
...
CPT: Pharmacometrics & Systems Pharmacology. 9 (2019) 1 - p. 48-59 , 2019
Link:
https://doi.org/10.1002/..
?
15
Population pharmacokinetics, exposure-safety, and immunogen..:
Shemesh, Colby S.
;
Chanu, Pascal
;
Jamsen, Kris
...
Journal for ImmunoTherapy of Cancer. 7 (2019) 1 - p. , 2019
Link:
https://doi.org/10.1186/..
1-15